{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:50:56Z","timestamp":1693227056130},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114985","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T20:16:36Z","timestamp":1418415396000},"page":"e114985","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of Dual-Activity Vectors by Co-Envelopment of Adenovirus and SiRNA in Artificial Lipid Bilayers"],"prefix":"10.1371","volume":"9","author":[{"given":"A\u00e7elya","family":"Yilmazer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Kostarelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1158\/0008-5472.CAN-06-1617","article-title":"Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA","volume":"66","author":"Y-A Zhang","year":"2006","journal-title":"Cancer Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mt.2008.236","article-title":"Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors","volume":"17","author":"H Zhang","year":"2008","journal-title":"Mol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/02841860701403053","article-title":"Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC","volume":"47","author":"Q Pan","year":"2008","journal-title":"Acta Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1756-9966-28-81","article-title":"Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo","volume":"28","author":"W Shen","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/cgt.2008.61","article-title":"Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA","volume":"16","author":"JN Zheng","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/nn8000565","article-title":"Nanoengineering Artificial Lipid Envelopes Around Adenovirus by Self-Assembly","volume":"2","author":"R Singh","year":"2008","journal-title":"ACS Nano"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1096\/fj.08-103275","article-title":"Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo","volume":"22","author":"R Singh","year":"2008","journal-title":"FASEB J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.biomaterials.2010.12.043","article-title":"Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo","volume":"32","author":"J Van den Bossche","year":"2011","journal-title":"Biomaterials"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17337","DOI":"10.1073\/pnas.0607015103","article-title":"Small dsRNAs induce transcriptional activation in human cells","volume":"103","author":"L-C Li","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1000258","DOI":"10.1371\/journal.pgen.1000258","article-title":"Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells","volume":"4","author":"KV Morris","year":"2008","journal-title":"PLoS Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbamem.2004.04.003","article-title":"DOTAP\/DOPE and DC-Chol\/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra","volume":"1664","author":"L Ciani","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.gt.3302050","article-title":"A comparison of linear and branched polyethylenimine (PEI) with DCChol\/\/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo","volume":"10","author":"JW Wiseman","year":"2003","journal-title":"Gene Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.01.035","article-title":"DC-Chol\/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery","volume":"390","author":"Y Zhang","year":"2010","journal-title":"Int J Pharm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2014.00074","article-title":"Armed therapeutic viruses \u2013 a disruptive therapy on the horizon of cancer immunotherapy","volume":"5","author":"M Bauzon","year":"2014","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"572609","DOI":"10.1155\/2013\/572609","article-title":"A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine","volume":"2013","author":"Y Tada","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/v2010078","article-title":"Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles","volume":"2","author":"HH Wong","year":"2010","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4161\/cbt.8.1.7204","article-title":"Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene","volume":"8","author":"J-N Zheng","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.biomaterials.2012.10.053","article-title":"The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity","volume":"34","author":"A Yilmazer","year":"2013","journal-title":"Biomaterials"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.addr.2013.10.003","article-title":"Carbon nanotubes as vectors for gene therapy: Past achievements, present challenges and future goals","volume":"65","author":"K Bates","year":"2013","journal-title":"Adv Drug Delivery Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.addr.2013.12.008","article-title":"Liposomal siRNA nanocarriers for cancer therapy","volume":"66","author":"B Ozpolat","year":"2014","journal-title":"Adv Drug Delivery Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.addr.2013.11.006","article-title":"Stable RNA nanoparticles as potential new generation drugs for cancer therapy","volume":"66","author":"Y Shu","year":"2014","journal-title":"Adv Drug Delivery Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/adma.201204346","article-title":"Degradable Terpolymers with Alkyl Side Chains Demonstrate Enhanced Gene Delivery Potency and Nanoparticle Stability","volume":"25","author":"AA Eltoukhy","year":"2013","journal-title":"Adv Mater"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"R Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/mt.2009.208","article-title":"Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment","volume":"18","author":"MT Abrams","year":"2009","journal-title":"Mol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1755-148X.2009.00581.x","article-title":"Use of liposomes as drug delivery vehicles for treatment of melanoma","volume":"22","author":"MA Tran","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1016\/j.biomaterials.2011.03.042","article-title":"Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide","volume":"32","author":"H Chang Kang","year":"2011","journal-title":"Biomaterials"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbagen.2009.01.005","article-title":"How to make siRNA lipoplexes efficient? Add a DNA cargo","volume":"1790","author":"H Rhinn","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2006.09.057","article-title":"The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex","volume":"333","author":"T Tagami","year":"2007","journal-title":"Int JPharm"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1016\/j.biomaterials.2012.01.027","article-title":"Simultaneous gene transduction and silencing using stimuli-responsive viral\/nonviral chimeric nanoparticles","volume":"33","author":"SK Cho","year":"2012","journal-title":"Biomaterials"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2009.02191.x","article-title":"Nanomedicine based approaches for the delivery of siRNA in cancer","volume":"267","author":"B Ozpolat","year":"2009","journal-title":"J Intern Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:43:07Z","timestamp":1589017387000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114985"}},"subtitle":[],"editor":[{"given":"Saw-See","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114985","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}